TrialInternational journal of chronic obstructive pulmonary disease

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.

Fernando J Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.